MACROMOLECULES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1200250, encodeId=c9301200250fc, content=请问该杂志是否接受临床研究类的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8922038196, createdName=1861e913cam, createdTime=Mon Mar 07 16:12:13 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094774, encodeId=80b61094e7410, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094773, encodeId=8b041094e738a, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856140, encodeId=45e685614043, content=接受了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba65413994, createdName=ms6179535627532318, createdTime=Mon Dec 23 16:31:29 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853648, encodeId=82a985364811, content=从最初投稿到网上见刊刚好三个月，中间还经历了大修小修，期刊的响应时间可以说相当快了，这里特别要感谢大分子副主编李良彬教授，非常负责和严谨。首先投稿之后编辑迅速送审，共返回三个审稿人意见，一个大修一个小修，还有一个建议转投，编辑给了大修。然后作者认真修改文章和回复审稿人意见，编辑将文章再返给三位审稿人，这次前两位审稿人都同意发表，第三位审稿人仍不同意，编辑又给了再次修改的机会。作者着重回复了第三位审稿人，并详细解释了实验细节，经过一周多的时间，文章终于被接收。 ps：在校完稿之后，系统会发邮件告知在48-72小时之内文章就会在网上见刊，但这个时间也并不完全准确，像我的就等了差不多一个星期才见刊...... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eed5414136, createdName=ms3195791918035402, createdTime=Sun Sep 08 17:47:02 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853647, encodeId=d59885364e23, content=大分子作为高分子领域的权威期刊，在业内倍受认可。从编辑到审稿人等各个环节，处理速度都没得说，很有大刊风范，acs的投稿系统也比较人性化，推荐大家投此期刊。我的整个投稿流程如下，时间不保证完全准确，仅供大家参考： 2019.06.06 submitted 2019.06.08 under review 2019.06.30 major revision 2019.07.18 resubmitted 2019.08.08 minor revision 2019.08.15 resubmitted 2019.08.26 accepted 2019.08.31 proof review 2019.09.06 published online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sun Sep 08 17:34:22 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851540, encodeId=9a3885154068, content=审稿速度:2.0 经验分享：2019年3月19号，投稿。50天后返回审稿意见，大修。8天后回复审稿人意见，返回修改稿。3天后直接接受。总体感觉速度还可以。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Thu May 23 10:47:46 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838742, encodeId=fb8d838e42ed, content=9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。直到今天，10.15了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息 注意：1.审稿速度是随便填的，因为现在还没收到任何消息 2.之前的时间敲错了，再次更正一下 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27a45414023, createdName=ms2983094698733738, createdTime=Sun Oct 15 17:25:09 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838741, encodeId=f35a838e4132, content=9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。知道今天，10.18了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Sun Oct 15 17:20:51 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544246, encodeId=967554424663, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2022-03-07 1861e913cam

请问该杂志是否接受临床研究类的文章？

58 0

[GetPortalCommentsPageByObjectIdResponse(id=1200250, encodeId=c9301200250fc, content=请问该杂志是否接受临床研究类的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8922038196, createdName=1861e913cam, createdTime=Mon Mar 07 16:12:13 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094774, encodeId=80b61094e7410, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094773, encodeId=8b041094e738a, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856140, encodeId=45e685614043, content=接受了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba65413994, createdName=ms6179535627532318, createdTime=Mon Dec 23 16:31:29 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853648, encodeId=82a985364811, content=从最初投稿到网上见刊刚好三个月，中间还经历了大修小修，期刊的响应时间可以说相当快了，这里特别要感谢大分子副主编李良彬教授，非常负责和严谨。首先投稿之后编辑迅速送审，共返回三个审稿人意见，一个大修一个小修，还有一个建议转投，编辑给了大修。然后作者认真修改文章和回复审稿人意见，编辑将文章再返给三位审稿人，这次前两位审稿人都同意发表，第三位审稿人仍不同意，编辑又给了再次修改的机会。作者着重回复了第三位审稿人，并详细解释了实验细节，经过一周多的时间，文章终于被接收。 ps：在校完稿之后，系统会发邮件告知在48-72小时之内文章就会在网上见刊，但这个时间也并不完全准确，像我的就等了差不多一个星期才见刊...... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eed5414136, createdName=ms3195791918035402, createdTime=Sun Sep 08 17:47:02 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853647, encodeId=d59885364e23, content=大分子作为高分子领域的权威期刊，在业内倍受认可。从编辑到审稿人等各个环节，处理速度都没得说，很有大刊风范，acs的投稿系统也比较人性化，推荐大家投此期刊。我的整个投稿流程如下，时间不保证完全准确，仅供大家参考： 2019.06.06 submitted 2019.06.08 under review 2019.06.30 major revision 2019.07.18 resubmitted 2019.08.08 minor revision 2019.08.15 resubmitted 2019.08.26 accepted 2019.08.31 proof review 2019.09.06 published online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sun Sep 08 17:34:22 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851540, encodeId=9a3885154068, content=审稿速度:2.0 经验分享：2019年3月19号，投稿。50天后返回审稿意见，大修。8天后回复审稿人意见，返回修改稿。3天后直接接受。总体感觉速度还可以。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Thu May 23 10:47:46 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838742, encodeId=fb8d838e42ed, content=9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。直到今天，10.15了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息 注意：1.审稿速度是随便填的，因为现在还没收到任何消息 2.之前的时间敲错了，再次更正一下 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27a45414023, createdName=ms2983094698733738, createdTime=Sun Oct 15 17:25:09 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838741, encodeId=f35a838e4132, content=9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。知道今天，10.18了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Sun Oct 15 17:20:51 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544246, encodeId=967554424663, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2021-12-29 衣谷

摘要一定要描述使用的方法么？

71 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1200250, encodeId=c9301200250fc, content=请问该杂志是否接受临床研究类的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8922038196, createdName=1861e913cam, createdTime=Mon Mar 07 16:12:13 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094774, encodeId=80b61094e7410, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094773, encodeId=8b041094e738a, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856140, encodeId=45e685614043, content=接受了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba65413994, createdName=ms6179535627532318, createdTime=Mon Dec 23 16:31:29 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853648, encodeId=82a985364811, content=从最初投稿到网上见刊刚好三个月，中间还经历了大修小修，期刊的响应时间可以说相当快了，这里特别要感谢大分子副主编李良彬教授，非常负责和严谨。首先投稿之后编辑迅速送审，共返回三个审稿人意见，一个大修一个小修，还有一个建议转投，编辑给了大修。然后作者认真修改文章和回复审稿人意见，编辑将文章再返给三位审稿人，这次前两位审稿人都同意发表，第三位审稿人仍不同意，编辑又给了再次修改的机会。作者着重回复了第三位审稿人，并详细解释了实验细节，经过一周多的时间，文章终于被接收。 ps：在校完稿之后，系统会发邮件告知在48-72小时之内文章就会在网上见刊，但这个时间也并不完全准确，像我的就等了差不多一个星期才见刊...... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eed5414136, createdName=ms3195791918035402, createdTime=Sun Sep 08 17:47:02 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853647, encodeId=d59885364e23, content=大分子作为高分子领域的权威期刊，在业内倍受认可。从编辑到审稿人等各个环节，处理速度都没得说，很有大刊风范，acs的投稿系统也比较人性化，推荐大家投此期刊。我的整个投稿流程如下，时间不保证完全准确，仅供大家参考： 2019.06.06 submitted 2019.06.08 under review 2019.06.30 major revision 2019.07.18 resubmitted 2019.08.08 minor revision 2019.08.15 resubmitted 2019.08.26 accepted 2019.08.31 proof review 2019.09.06 published online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sun Sep 08 17:34:22 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851540, encodeId=9a3885154068, content=审稿速度:2.0 经验分享：2019年3月19号，投稿。50天后返回审稿意见，大修。8天后回复审稿人意见，返回修改稿。3天后直接接受。总体感觉速度还可以。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Thu May 23 10:47:46 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838742, encodeId=fb8d838e42ed, content=9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。直到今天，10.15了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息 注意：1.审稿速度是随便填的，因为现在还没收到任何消息 2.之前的时间敲错了，再次更正一下 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27a45414023, createdName=ms2983094698733738, createdTime=Sun Oct 15 17:25:09 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838741, encodeId=f35a838e4132, content=9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。知道今天，10.18了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Sun Oct 15 17:20:51 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544246, encodeId=967554424663, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2021-12-29 桑晒麦拉

摘要和HIGHLIGHTS的区别？

44 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1200250, encodeId=c9301200250fc, content=请问该杂志是否接受临床研究类的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8922038196, createdName=1861e913cam, createdTime=Mon Mar 07 16:12:13 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094774, encodeId=80b61094e7410, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094773, encodeId=8b041094e738a, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856140, encodeId=45e685614043, content=接受了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba65413994, createdName=ms6179535627532318, createdTime=Mon Dec 23 16:31:29 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853648, encodeId=82a985364811, content=从最初投稿到网上见刊刚好三个月，中间还经历了大修小修，期刊的响应时间可以说相当快了，这里特别要感谢大分子副主编李良彬教授，非常负责和严谨。首先投稿之后编辑迅速送审，共返回三个审稿人意见，一个大修一个小修，还有一个建议转投，编辑给了大修。然后作者认真修改文章和回复审稿人意见，编辑将文章再返给三位审稿人，这次前两位审稿人都同意发表，第三位审稿人仍不同意，编辑又给了再次修改的机会。作者着重回复了第三位审稿人，并详细解释了实验细节，经过一周多的时间，文章终于被接收。 ps：在校完稿之后，系统会发邮件告知在48-72小时之内文章就会在网上见刊，但这个时间也并不完全准确，像我的就等了差不多一个星期才见刊...... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eed5414136, createdName=ms3195791918035402, createdTime=Sun Sep 08 17:47:02 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853647, encodeId=d59885364e23, content=大分子作为高分子领域的权威期刊，在业内倍受认可。从编辑到审稿人等各个环节，处理速度都没得说，很有大刊风范，acs的投稿系统也比较人性化，推荐大家投此期刊。我的整个投稿流程如下，时间不保证完全准确，仅供大家参考： 2019.06.06 submitted 2019.06.08 under review 2019.06.30 major revision 2019.07.18 resubmitted 2019.08.08 minor revision 2019.08.15 resubmitted 2019.08.26 accepted 2019.08.31 proof review 2019.09.06 published online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sun Sep 08 17:34:22 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851540, encodeId=9a3885154068, content=审稿速度:2.0 经验分享：2019年3月19号，投稿。50天后返回审稿意见，大修。8天后回复审稿人意见，返回修改稿。3天后直接接受。总体感觉速度还可以。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Thu May 23 10:47:46 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838742, encodeId=fb8d838e42ed, content=9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。直到今天，10.15了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息 注意：1.审稿速度是随便填的，因为现在还没收到任何消息 2.之前的时间敲错了，再次更正一下 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27a45414023, createdName=ms2983094698733738, createdTime=Sun Oct 15 17:25:09 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838741, encodeId=f35a838e4132, content=9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。知道今天，10.18了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Sun Oct 15 17:20:51 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544246, encodeId=967554424663, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2019-12-23 ms6179535627532318

接受了

149 0

[GetPortalCommentsPageByObjectIdResponse(id=1200250, encodeId=c9301200250fc, content=请问该杂志是否接受临床研究类的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8922038196, createdName=1861e913cam, createdTime=Mon Mar 07 16:12:13 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094774, encodeId=80b61094e7410, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094773, encodeId=8b041094e738a, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856140, encodeId=45e685614043, content=接受了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba65413994, createdName=ms6179535627532318, createdTime=Mon Dec 23 16:31:29 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853648, encodeId=82a985364811, content=从最初投稿到网上见刊刚好三个月，中间还经历了大修小修，期刊的响应时间可以说相当快了，这里特别要感谢大分子副主编李良彬教授，非常负责和严谨。首先投稿之后编辑迅速送审，共返回三个审稿人意见，一个大修一个小修，还有一个建议转投，编辑给了大修。然后作者认真修改文章和回复审稿人意见，编辑将文章再返给三位审稿人，这次前两位审稿人都同意发表，第三位审稿人仍不同意，编辑又给了再次修改的机会。作者着重回复了第三位审稿人，并详细解释了实验细节，经过一周多的时间，文章终于被接收。 ps：在校完稿之后，系统会发邮件告知在48-72小时之内文章就会在网上见刊，但这个时间也并不完全准确，像我的就等了差不多一个星期才见刊...... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eed5414136, createdName=ms3195791918035402, createdTime=Sun Sep 08 17:47:02 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853647, encodeId=d59885364e23, content=大分子作为高分子领域的权威期刊，在业内倍受认可。从编辑到审稿人等各个环节，处理速度都没得说，很有大刊风范，acs的投稿系统也比较人性化，推荐大家投此期刊。我的整个投稿流程如下，时间不保证完全准确，仅供大家参考： 2019.06.06 submitted 2019.06.08 under review 2019.06.30 major revision 2019.07.18 resubmitted 2019.08.08 minor revision 2019.08.15 resubmitted 2019.08.26 accepted 2019.08.31 proof review 2019.09.06 published online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sun Sep 08 17:34:22 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851540, encodeId=9a3885154068, content=审稿速度:2.0 经验分享：2019年3月19号，投稿。50天后返回审稿意见，大修。8天后回复审稿人意见，返回修改稿。3天后直接接受。总体感觉速度还可以。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Thu May 23 10:47:46 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838742, encodeId=fb8d838e42ed, content=9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。直到今天，10.15了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息 注意：1.审稿速度是随便填的，因为现在还没收到任何消息 2.之前的时间敲错了，再次更正一下 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27a45414023, createdName=ms2983094698733738, createdTime=Sun Oct 15 17:25:09 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838741, encodeId=f35a838e4132, content=9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。知道今天，10.18了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Sun Oct 15 17:20:51 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544246, encodeId=967554424663, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2019-09-08 ms3195791918035402

从最初投稿到网上见刊刚好三个月，中间还经历了大修小修，期刊的响应时间可以说相当快了，这里特别要感谢大分子副主编李良彬教授，非常负责和严谨。首先投稿之后编辑迅速送审，共返回三个审稿人意见，一个大修一个小修，还有一个建议转投，编辑给了大修。然后作者认真修改文章和回复审稿人意见，编辑将文章再返给三位审稿人，这次前两位审稿人都同意发表，第三位审稿人仍不同意，编辑又给了再次修改的机会。作者着重回复了第三位审稿人，并详细解释了实验细节，经过一周多的时间，文章终于被接收。
ps：在校完稿之后，系统会发邮件告知在48-72小时之内文章就会在网上见刊，但这个时间也并不完全准确，像我的就等了差不多一个星期才见刊......

145 0

[GetPortalCommentsPageByObjectIdResponse(id=1200250, encodeId=c9301200250fc, content=请问该杂志是否接受临床研究类的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8922038196, createdName=1861e913cam, createdTime=Mon Mar 07 16:12:13 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094774, encodeId=80b61094e7410, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094773, encodeId=8b041094e738a, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856140, encodeId=45e685614043, content=接受了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba65413994, createdName=ms6179535627532318, createdTime=Mon Dec 23 16:31:29 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853648, encodeId=82a985364811, content=从最初投稿到网上见刊刚好三个月，中间还经历了大修小修，期刊的响应时间可以说相当快了，这里特别要感谢大分子副主编李良彬教授，非常负责和严谨。首先投稿之后编辑迅速送审，共返回三个审稿人意见，一个大修一个小修，还有一个建议转投，编辑给了大修。然后作者认真修改文章和回复审稿人意见，编辑将文章再返给三位审稿人，这次前两位审稿人都同意发表，第三位审稿人仍不同意，编辑又给了再次修改的机会。作者着重回复了第三位审稿人，并详细解释了实验细节，经过一周多的时间，文章终于被接收。 ps：在校完稿之后，系统会发邮件告知在48-72小时之内文章就会在网上见刊，但这个时间也并不完全准确，像我的就等了差不多一个星期才见刊...... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eed5414136, createdName=ms3195791918035402, createdTime=Sun Sep 08 17:47:02 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853647, encodeId=d59885364e23, content=大分子作为高分子领域的权威期刊，在业内倍受认可。从编辑到审稿人等各个环节，处理速度都没得说，很有大刊风范，acs的投稿系统也比较人性化，推荐大家投此期刊。我的整个投稿流程如下，时间不保证完全准确，仅供大家参考： 2019.06.06 submitted 2019.06.08 under review 2019.06.30 major revision 2019.07.18 resubmitted 2019.08.08 minor revision 2019.08.15 resubmitted 2019.08.26 accepted 2019.08.31 proof review 2019.09.06 published online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sun Sep 08 17:34:22 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851540, encodeId=9a3885154068, content=审稿速度:2.0 经验分享：2019年3月19号，投稿。50天后返回审稿意见，大修。8天后回复审稿人意见，返回修改稿。3天后直接接受。总体感觉速度还可以。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Thu May 23 10:47:46 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838742, encodeId=fb8d838e42ed, content=9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。直到今天，10.15了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息 注意：1.审稿速度是随便填的，因为现在还没收到任何消息 2.之前的时间敲错了，再次更正一下 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27a45414023, createdName=ms2983094698733738, createdTime=Sun Oct 15 17:25:09 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838741, encodeId=f35a838e4132, content=9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。知道今天，10.18了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Sun Oct 15 17:20:51 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544246, encodeId=967554424663, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2019-09-08 ms9495958415321966

大分子作为高分子领域的权威期刊，在业内倍受认可。从编辑到审稿人等各个环节，处理速度都没得说，很有大刊风范，acs的投稿系统也比较人性化，推荐大家投此期刊。我的整个投稿流程如下，时间不保证完全准确，仅供大家参考：
2019.06.06 submitted
2019.06.08 under review
2019.06.30 major revision
2019.07.18 resubmitted
2019.08.08 minor revision
2019.08.15 resubmitted
2019.08.26 accepted
2019.08.31 proof review
2019.09.06 published online

151 0

[GetPortalCommentsPageByObjectIdResponse(id=1200250, encodeId=c9301200250fc, content=请问该杂志是否接受临床研究类的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8922038196, createdName=1861e913cam, createdTime=Mon Mar 07 16:12:13 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094774, encodeId=80b61094e7410, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094773, encodeId=8b041094e738a, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856140, encodeId=45e685614043, content=接受了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba65413994, createdName=ms6179535627532318, createdTime=Mon Dec 23 16:31:29 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853648, encodeId=82a985364811, content=从最初投稿到网上见刊刚好三个月，中间还经历了大修小修，期刊的响应时间可以说相当快了，这里特别要感谢大分子副主编李良彬教授，非常负责和严谨。首先投稿之后编辑迅速送审，共返回三个审稿人意见，一个大修一个小修，还有一个建议转投，编辑给了大修。然后作者认真修改文章和回复审稿人意见，编辑将文章再返给三位审稿人，这次前两位审稿人都同意发表，第三位审稿人仍不同意，编辑又给了再次修改的机会。作者着重回复了第三位审稿人，并详细解释了实验细节，经过一周多的时间，文章终于被接收。 ps：在校完稿之后，系统会发邮件告知在48-72小时之内文章就会在网上见刊，但这个时间也并不完全准确，像我的就等了差不多一个星期才见刊...... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eed5414136, createdName=ms3195791918035402, createdTime=Sun Sep 08 17:47:02 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853647, encodeId=d59885364e23, content=大分子作为高分子领域的权威期刊，在业内倍受认可。从编辑到审稿人等各个环节，处理速度都没得说，很有大刊风范，acs的投稿系统也比较人性化，推荐大家投此期刊。我的整个投稿流程如下，时间不保证完全准确，仅供大家参考： 2019.06.06 submitted 2019.06.08 under review 2019.06.30 major revision 2019.07.18 resubmitted 2019.08.08 minor revision 2019.08.15 resubmitted 2019.08.26 accepted 2019.08.31 proof review 2019.09.06 published online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sun Sep 08 17:34:22 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851540, encodeId=9a3885154068, content=审稿速度:2.0 经验分享：2019年3月19号，投稿。50天后返回审稿意见，大修。8天后回复审稿人意见，返回修改稿。3天后直接接受。总体感觉速度还可以。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Thu May 23 10:47:46 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838742, encodeId=fb8d838e42ed, content=9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。直到今天，10.15了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息 注意：1.审稿速度是随便填的，因为现在还没收到任何消息 2.之前的时间敲错了，再次更正一下 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27a45414023, createdName=ms2983094698733738, createdTime=Sun Oct 15 17:25:09 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838741, encodeId=f35a838e4132, content=9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。知道今天，10.18了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Sun Oct 15 17:20:51 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544246, encodeId=967554424663, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2019-05-23 ms9495958415321966

审稿速度:2.0
经验分享：2019年3月19号，投稿。50天后返回审稿意见，大修。8天后回复审稿人意见，返回修改稿。3天后直接接受。总体感觉速度还可以。

133 0

[GetPortalCommentsPageByObjectIdResponse(id=1200250, encodeId=c9301200250fc, content=请问该杂志是否接受临床研究类的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8922038196, createdName=1861e913cam, createdTime=Mon Mar 07 16:12:13 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094774, encodeId=80b61094e7410, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094773, encodeId=8b041094e738a, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856140, encodeId=45e685614043, content=接受了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba65413994, createdName=ms6179535627532318, createdTime=Mon Dec 23 16:31:29 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853648, encodeId=82a985364811, content=从最初投稿到网上见刊刚好三个月，中间还经历了大修小修，期刊的响应时间可以说相当快了，这里特别要感谢大分子副主编李良彬教授，非常负责和严谨。首先投稿之后编辑迅速送审，共返回三个审稿人意见，一个大修一个小修，还有一个建议转投，编辑给了大修。然后作者认真修改文章和回复审稿人意见，编辑将文章再返给三位审稿人，这次前两位审稿人都同意发表，第三位审稿人仍不同意，编辑又给了再次修改的机会。作者着重回复了第三位审稿人，并详细解释了实验细节，经过一周多的时间，文章终于被接收。 ps：在校完稿之后，系统会发邮件告知在48-72小时之内文章就会在网上见刊，但这个时间也并不完全准确，像我的就等了差不多一个星期才见刊...... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eed5414136, createdName=ms3195791918035402, createdTime=Sun Sep 08 17:47:02 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853647, encodeId=d59885364e23, content=大分子作为高分子领域的权威期刊，在业内倍受认可。从编辑到审稿人等各个环节，处理速度都没得说，很有大刊风范，acs的投稿系统也比较人性化，推荐大家投此期刊。我的整个投稿流程如下，时间不保证完全准确，仅供大家参考： 2019.06.06 submitted 2019.06.08 under review 2019.06.30 major revision 2019.07.18 resubmitted 2019.08.08 minor revision 2019.08.15 resubmitted 2019.08.26 accepted 2019.08.31 proof review 2019.09.06 published online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sun Sep 08 17:34:22 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851540, encodeId=9a3885154068, content=审稿速度:2.0 经验分享：2019年3月19号，投稿。50天后返回审稿意见，大修。8天后回复审稿人意见，返回修改稿。3天后直接接受。总体感觉速度还可以。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Thu May 23 10:47:46 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838742, encodeId=fb8d838e42ed, content=9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。直到今天，10.15了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息 注意：1.审稿速度是随便填的，因为现在还没收到任何消息 2.之前的时间敲错了，再次更正一下 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27a45414023, createdName=ms2983094698733738, createdTime=Sun Oct 15 17:25:09 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838741, encodeId=f35a838e4132, content=9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。知道今天，10.18了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Sun Oct 15 17:20:51 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544246, encodeId=967554424663, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2017-10-15 ms2983094698733738

9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。直到今天，10.15了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息
注意：1.审稿速度是随便填的，因为现在还没收到任何消息
2.之前的时间敲错了，再次更正一下

155 0

[GetPortalCommentsPageByObjectIdResponse(id=1200250, encodeId=c9301200250fc, content=请问该杂志是否接受临床研究类的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8922038196, createdName=1861e913cam, createdTime=Mon Mar 07 16:12:13 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094774, encodeId=80b61094e7410, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094773, encodeId=8b041094e738a, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856140, encodeId=45e685614043, content=接受了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba65413994, createdName=ms6179535627532318, createdTime=Mon Dec 23 16:31:29 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853648, encodeId=82a985364811, content=从最初投稿到网上见刊刚好三个月，中间还经历了大修小修，期刊的响应时间可以说相当快了，这里特别要感谢大分子副主编李良彬教授，非常负责和严谨。首先投稿之后编辑迅速送审，共返回三个审稿人意见，一个大修一个小修，还有一个建议转投，编辑给了大修。然后作者认真修改文章和回复审稿人意见，编辑将文章再返给三位审稿人，这次前两位审稿人都同意发表，第三位审稿人仍不同意，编辑又给了再次修改的机会。作者着重回复了第三位审稿人，并详细解释了实验细节，经过一周多的时间，文章终于被接收。 ps：在校完稿之后，系统会发邮件告知在48-72小时之内文章就会在网上见刊，但这个时间也并不完全准确，像我的就等了差不多一个星期才见刊...... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eed5414136, createdName=ms3195791918035402, createdTime=Sun Sep 08 17:47:02 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853647, encodeId=d59885364e23, content=大分子作为高分子领域的权威期刊，在业内倍受认可。从编辑到审稿人等各个环节，处理速度都没得说，很有大刊风范，acs的投稿系统也比较人性化，推荐大家投此期刊。我的整个投稿流程如下，时间不保证完全准确，仅供大家参考： 2019.06.06 submitted 2019.06.08 under review 2019.06.30 major revision 2019.07.18 resubmitted 2019.08.08 minor revision 2019.08.15 resubmitted 2019.08.26 accepted 2019.08.31 proof review 2019.09.06 published online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sun Sep 08 17:34:22 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851540, encodeId=9a3885154068, content=审稿速度:2.0 经验分享：2019年3月19号，投稿。50天后返回审稿意见，大修。8天后回复审稿人意见，返回修改稿。3天后直接接受。总体感觉速度还可以。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Thu May 23 10:47:46 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838742, encodeId=fb8d838e42ed, content=9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。直到今天，10.15了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息 注意：1.审稿速度是随便填的，因为现在还没收到任何消息 2.之前的时间敲错了，再次更正一下 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27a45414023, createdName=ms2983094698733738, createdTime=Sun Oct 15 17:25:09 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838741, encodeId=f35a838e4132, content=9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。知道今天，10.18了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Sun Oct 15 17:20:51 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544246, encodeId=967554424663, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2017-10-15 ms887994580797846

9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。知道今天，10.18了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息

138 0

[GetPortalCommentsPageByObjectIdResponse(id=1200250, encodeId=c9301200250fc, content=请问该杂志是否接受临床研究类的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8922038196, createdName=1861e913cam, createdTime=Mon Mar 07 16:12:13 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094774, encodeId=80b61094e7410, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094773, encodeId=8b041094e738a, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856140, encodeId=45e685614043, content=接受了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba65413994, createdName=ms6179535627532318, createdTime=Mon Dec 23 16:31:29 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853648, encodeId=82a985364811, content=从最初投稿到网上见刊刚好三个月，中间还经历了大修小修，期刊的响应时间可以说相当快了，这里特别要感谢大分子副主编李良彬教授，非常负责和严谨。首先投稿之后编辑迅速送审，共返回三个审稿人意见，一个大修一个小修，还有一个建议转投，编辑给了大修。然后作者认真修改文章和回复审稿人意见，编辑将文章再返给三位审稿人，这次前两位审稿人都同意发表，第三位审稿人仍不同意，编辑又给了再次修改的机会。作者着重回复了第三位审稿人，并详细解释了实验细节，经过一周多的时间，文章终于被接收。 ps：在校完稿之后，系统会发邮件告知在48-72小时之内文章就会在网上见刊，但这个时间也并不完全准确，像我的就等了差不多一个星期才见刊...... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eed5414136, createdName=ms3195791918035402, createdTime=Sun Sep 08 17:47:02 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853647, encodeId=d59885364e23, content=大分子作为高分子领域的权威期刊，在业内倍受认可。从编辑到审稿人等各个环节，处理速度都没得说，很有大刊风范，acs的投稿系统也比较人性化，推荐大家投此期刊。我的整个投稿流程如下，时间不保证完全准确，仅供大家参考： 2019.06.06 submitted 2019.06.08 under review 2019.06.30 major revision 2019.07.18 resubmitted 2019.08.08 minor revision 2019.08.15 resubmitted 2019.08.26 accepted 2019.08.31 proof review 2019.09.06 published online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sun Sep 08 17:34:22 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851540, encodeId=9a3885154068, content=审稿速度:2.0 经验分享：2019年3月19号，投稿。50天后返回审稿意见，大修。8天后回复审稿人意见，返回修改稿。3天后直接接受。总体感觉速度还可以。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Thu May 23 10:47:46 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838742, encodeId=fb8d838e42ed, content=9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。直到今天，10.15了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息 注意：1.审稿速度是随便填的，因为现在还没收到任何消息 2.之前的时间敲错了，再次更正一下 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27a45414023, createdName=ms2983094698733738, createdTime=Sun Oct 15 17:25:09 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838741, encodeId=f35a838e4132, content=9.30号晚上投稿，10.3号让填一个agreement，4号打开邮箱看到后立马回复，由于是第一次投稿，所以鼓捣了一个来小时，中午之前提交的。知道今天，10.18了，还是submitted to editorial office……前天晚上梦到被拒稿，哎……焦急啊，也许，真的是没有消息就是最好的消息 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Sun Oct 15 17:20:51 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544246, encodeId=967554424663, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2017-07-16 zheyang

还是5分多,虽然没有大变化,能稳定在些,也算是中上等

257 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务